Glaukos (GKOS) Shares Outstanding (2014 - 2026)
Glaukos (GKOS) posted quarterly Shares Outstanding (Entity) of $58.9 million for Q2 2026, up 2.81% year-over-year from $57.3 million in Q2 2025, and up 0.85% quarter-over-quarter from $58.4 million in Q1 2026.
Glaukos (GKOS) Shares Outstanding (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Shares Outstanding (Entity) for 13 consecutive years, with $58.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 2.81% year-over-year to $58.9 million; the TTM figure through Jun 2026 stood at $58.9 million (up 2.81% YoY), while the FY2025 annual figure was $57.5 million, up 1.89% from the prior year.
- Shares Outstanding (Entity) climbed to $58.9 million in Q2 2026 per GKOS's latest filing, from $58.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $58.9 million in Q2 2026 and bottomed at $47.1 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $52.6 million across 5 years, with a median of $52.4 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) gained 1.68% — and 2024, when it increased 14.9%.
- Glaukos' Shares Outstanding (Entity) stood at $47.8 million in 2022, then gained by 2.86% to $49.1 million in 2023, then climbed by 14.9% to $56.5 million in 2024, then rose by 1.89% to $57.5 million in 2025, then increased by 2.34% to $58.9 million in 2026.
- Business Quant data shows GKOS's Shares Outstanding (Entity) at $58.9 million in Q2 2026, $58.4 million in Q1 2026, and $57.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Glaukos | 11.19 Bn | 11.08 Bn | 151.59 Mn | 58.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.82 Mn |
| Mar 31, 2026 | 58.02 Mn |
| Dec 31, 2025 | 57.19 Mn |
| Sep 30, 2025 | 57.40 Mn |
| Jun 30, 2025 | 57.21 Mn |
| Mar 31, 2025 | 56.64 Mn |
| Dec 31, 2024 | 52.76 Mn |
| Sep 30, 2024 | 55.04 Mn |
| Jun 30, 2024 | 50.72 Mn |
| Mar 31, 2024 | 49.58 Mn |
| Dec 31, 2023 | 48.43 Mn |
| Sep 30, 2023 | 48.68 Mn |
| Jun 30, 2023 | 48.28 Mn |
| Mar 31, 2023 | 47.88 Mn |
| Dec 31, 2022 | 47.44 Mn |
| Sep 30, 2022 | 47.61 Mn |
| Jun 30, 2022 | 47.36 Mn |
| Mar 31, 2022 | 47.05 Mn |
| Dec 31, 2021 | 46.42 Mn |
| Sep 30, 2021 | 46.74 Mn |